Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebbe

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 casesR N Matin, D Mesher, C M Proby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesL Kandolf Sekulovic, J Guo, S Agarwala, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 yearsJ Y Blay, C Tlemsani, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort studyF Dimitriou, K Namikawa, I L M Reijers, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 13, 2008
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 casesR N Matin, D Mesher, C M Proby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesL Kandolf Sekulovic, J Guo, S Agarwala, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2023
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 yearsJ Y Blay, S Piperno-Neumann, S Watson, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2023
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 yearsJ Y Blay, C Tlemsani, M Toulmonde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort studyF Dimitriou, K Namikawa, I L M Reijers, et al.
Pageof 6